Information on pharmaceutical products for management of COVID-19
In collaboration with partners, UNICEF has made available a series of COVID-19 therapeutics products for deployment into COVID-19 programmes in low- and middle-income countries.
On the scroll down menu find the following documents with information on products that are available for procurement through UNICEF:
- An bulletin released in October 2022 with information on COVID-19 therapeutics products (i.e. Nirmatrelvir/Ritonavir tablets, Molnupiravir capsules and Dexamethasone).
- Dexamethasone inventory – March 2022 August 2020 – March 2022
- Information Note - Access to COVID-19 therapeutics products, released in March 2022.
- Information on Pharmaceutical Products for Management of COVID-19, published in September 2021.